Representative before the EPO

Employment test 51 - 200 employees
Company dna carpmarls and ransford
operating since 1848
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

Daniel Joseph Wise has worked on the following 32 EPO patent applications which have been published in the last five years:

EP12005524

Modified saccharides

IPC classification:
A61K 39/095, A61K 47/48, C07H 13/00, C08B 37/00
Applicant:
Novartis AG
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Agent:
Guido Pontremoli, GlaxoSmithKline S.A.
Status:
EXAMINATION IN PROGRESS
EP12176076

Single pluripotent stem cell culture

IPC classification:
C12N 5/0735
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP11799567

TISSUE ENGINEERED BLOOD VESSELS

IPC classification:
A61L 27/18, A61L 27/36, A61L 27/38, A61L 27/50
Applicant:
Cordis Corporation
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Agent:
Thomas Prock, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP12186995

Differentiation of human embryonic stem cells

IPC classification:
C12N 5/071
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13163291

Treatment of pluripotent cells

IPC classification:
C12N 5/0735
Applicant:
Janssen Biotech, Inc.
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12831075

METHODS OF DETECTING SEPSIS

IPC classification:
C40B 30/04, C40B 40/08
Applicant:
Cepheid Inc
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13155730

Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease

IPC classification:
C12N 5/07, C12N 5/071
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12775538

BACTERIUM FOR USE AS A PROBIOTIC FOR NUTRITIONAL AND MEDICAL APPLICATIONS

IPC classification:
A61K 35/74, A61P 1/00, A61P 37/00
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13185690

Vaccines including antigen from four strains of influenza virus

IPC classification:
A61K 39/145, A61P 31/16
Applicant:
Novartis AG
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12797981

ADJUVANTED INFLUENZA B VIRUS VACCINES FOR PEDIATRIC PRIMING

IPC classification:
A61K 39/145, A61P 31/16
Applicant:
Novartis AG
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP12777815

AN ASSAY OF CELL MEDIATED IMMUNE RESPONSIVENESS

IPC classification:
G01N 33/50
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP13754321

PAIN TREATMENT

IPC classification:
A61K 48/00, A61P 25/04, C12N 15/00, C12N 15/113, C12N 15/63
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Agent:
Martin Grund, Grund Intellectual Property Group
Status:
GRANT OF PATENT INTENDED
EP13758233

NOVEL TRIAZINE DERIVATIVE

IPC classification:
A61K 31/53, A61K 31/5377, A61P 19/00, A61P 29/00, A61P 35/00, A61P 35/02, A61P 37/06, A61P 43/00, C07D 251/42
Agent:
Wolf E. Sajda, Meissner Bolte & Partner GbR
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12804281

A CELL MEDIATED IMMUNE RESPONSE ASSAY WITH ENHANCED SENSITIVITY

IPC classification:
G01N 33/50
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13718488

METHODS OF DETECTING BLADDER CANCER

IPC classification:
C12Q 1/68
Applicant:
Cepheid Inc
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP14183359

Cell-derived viral vaccines with low levels of residual cell dna

IPC classification:
A61K 39/12, A61K 39/145
Applicant:
Novartis Vaccines and Diagnostics GmbH
Applicant:
Novartis Influenza Vaccines Marburg GmbH
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13726225

IMPROVED SAFETY TESTING

IPC classification:
A61K 39/12, C12Q 1/68
Applicant:
Novartis AG
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION WITHDRAWN
EP14187466

Artificial antigen presenting cell for preparing CD8 cell suspension for use in the treatment of cancer

IPC classification:
A61K 35/14, A61K 39/00, A61K 39/39, C12N 5/0784
Applicant:
Janssen Pharmaceuticals Inc.
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP11776962

THREADS OF CROSS-LINKED HYALURONIC ACID AND METHODS OF PREPARATION AND USE THEREOF

IPC classification:
A61L 15/28, A61L 27/20, A61L 31/04, C08B 37/00
Applicant:
Allergan Holdings France S.A.S.
Agent:
Hoffmann Eitle PartmbB
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP15154014

Influenza vaccination

IPC classification:
A61K 39/155, A61K 48/00
Applicant:
Novartis Vaccines and Diagnostics Inc.
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14705575

INFLUENZA VIRUS REASSORTMENT

IPC classification:
A61K 39/00, A61K 39/145, C07K 14/11, C12N 15/85
Applicant:
Novartis AG
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14743871

KV1.3 ANTAGONISTS AND METHODS OF USE

IPC classification:
A61K 48/00, C12P 19/34
Applicant:
Janssen Biotech, Inc.
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14722402

PALM ACTIVATED DRUG DELIVERY DEVICE

IPC classification:
A61M 5/168, A61M 5/20, A61M 5/315, A61M 5/32, A61M 5/42, A61M 5/48, A61M 5/50
Applicant:
Janssen Biotech, Inc.
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14768743

INTERFERON ALPHA AND OMEGA ANTIBODY ANTAGONISTS

IPC classification:
C07K 16/24
Applicant:
Janssen Biotech, Inc.
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP11798931

COLLAGEN-BINDING SYNTHETIC PEPTIDOGLYCANS FOR USE IN VASCULAR INTERVENTION

IPC classification:
A61K 45/00, A61P 9/00
Applicant:
Purdue Research Foundation (PRF)
Agent:
Grünecker Patent- und Rechtsanwälte PartG mbB
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14717823

ROSEBURIA FLAGELLIN AND IMMUNE MODULATION

IPC classification:
A61K 38/16, A61K 39/02, A61K 48/00, A61P 1/00, A61P 17/00, A61P 19/00, A61P 29/00, A61P 37/00, A23L 5/00
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP13171200

Methods for detecting and modulating the sensitivity of tumour cells to anti-mitotic agents

IPC classification:
A61K 31/165, A61K 31/7088, A61K 45/06, A61K 48/00, C12N 15/113, C12Q 1/68, G01N 33/483, G01N 33/50, G01N 33/574
Agent:
Andrea Gisela Lasar, Maiwald Patentanwalts GmbH
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP11767067

SOLUBLE NEEDLE ARRAYS FOR DELIVERY OF INFLUENZA VACCINES

IPC classification:
A61B 17/00, A61B 17/20, A61K 9/14, A61K 39/00, A61K 39/145, A61M 37/00
Applicant:
Novartis AG
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP11725975

INFLUENZA VIRUS REASSORTMENT METHOD

IPC classification:
A61K 39/145, C12N 7/02, C12N 15/113
Applicant:
Novartis AG
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12704581

NAPHTHYRIDINE DERIVATIVES AS INHIBITORS OF HYPOXIA INDUCIBLE FACTOR

IPC classification:
A61K 31/4375, A61P 9/10, C07D 471/04
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP11835635

HBV TREATMENT

IPC classification:
A61K 31/713, C12N 15/113
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Agent:
Martin Grund, Grund Intellectual Property Group
Status:
PATENT GRANTED
EP15724442

USE OF SMALL MOLECULES TO ENHANCE MAFA EXPRESSION IN PANCREATIC ENDOCRINE CELLS

IPC classification:
C12N 5/071
Applicant:
Janssen Biotech, Inc.
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature